Building capacity for new modalities: Inside Cytiva's first end-to-end cGMP facility for mRNA manufacturing [Yahoo! Finance]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance
In fact, the technology has been around since the 1960s. While many mRNA vaccines have been tested in clinical studies since that time, we are only now witnessing the first approvals. It was not until the onset of the COVID-19 pandemic, when the successful development by Moderna and BioNTech/Pfizer of their respective vaccines against COVID-19 proved mRNA to be effective and efficient, that the approach was validated. mRNA as an approach to making medicine has now proven itself on the largest stage imaginable, with more than 11.1 billion doses of COVID-19 vaccines administered worldwide. Biopharmaceutical companies are increasingly looking at how this technology can be used within smaller patient populations, including oncology and a wide range of infectious diseases. According to GlobalData, 2021 saw a particularly large increase in infectious disease mRNA vaccine trial starts, from an average of fewer than five clinical trial starts per year from 2017–19 up to 42 in 2020 and 296 i
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines [Yahoo! Finance]Yahoo! Finance
- Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine [Yahoo! Finance]Yahoo! Finance
- GSK Secures mRNA Vaccines For Bird Flu, COVID And Seasonal Flu From Struggling Biotech CureVac [Forbes]Forbes
- Moderna's mRNA influenza vaccine receives $176m boost [Yahoo! Finance]Yahoo! Finance
- Cytomegalovirus Infection Therapeutics Research 2024: Comprehensive Insights About 15+ Companies and 20+ Pipeline Drugs Featuring Vir, SpyBiotech, Moderna, VBI, Trellis Bioscience, GSK, & AlloVir [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 5/2/24 - Beat
MRNA
Sec Filings
- 6/28/24 - Form 4
- 6/26/24 - Form 144
- 6/21/24 - Form 4
- MRNA's page on the SEC website